1. Home
  2. DXCM vs CCEP Comparison

DXCM vs CCEP Comparison

Compare DXCM & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • CCEP
  • Stock Information
  • Founded
  • DXCM 1999
  • CCEP 1986
  • Country
  • DXCM United States
  • CCEP United Kingdom
  • Employees
  • DXCM N/A
  • CCEP N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • CCEP Beverages (Production/Distribution)
  • Sector
  • DXCM Health Care
  • CCEP Consumer Staples
  • Exchange
  • DXCM Nasdaq
  • CCEP Nasdaq
  • Market Cap
  • DXCM 35.7B
  • CCEP 37.9B
  • IPO Year
  • DXCM 2005
  • CCEP 1987
  • Fundamental
  • Price
  • DXCM $68.29
  • CCEP $87.03
  • Analyst Decision
  • DXCM Strong Buy
  • CCEP Buy
  • Analyst Count
  • DXCM 17
  • CCEP 7
  • Target Price
  • DXCM $99.82
  • CCEP $88.83
  • AVG Volume (30 Days)
  • DXCM 4.4M
  • CCEP 3.7M
  • Earning Date
  • DXCM 04-24-2025
  • CCEP 02-14-2025
  • Dividend Yield
  • DXCM N/A
  • CCEP 2.45%
  • EPS Growth
  • DXCM 9.35
  • CCEP N/A
  • EPS
  • DXCM 1.42
  • CCEP 3.19
  • Revenue
  • DXCM $4,033,000,000.00
  • CCEP $21,159,540,332.00
  • Revenue This Year
  • DXCM $16.49
  • CCEP $7.33
  • Revenue Next Year
  • DXCM $15.58
  • CCEP $3.82
  • P/E Ratio
  • DXCM $47.96
  • CCEP $27.29
  • Revenue Growth
  • DXCM 11.34
  • CCEP 11.67
  • 52 Week Low
  • DXCM $62.34
  • CCEP $65.94
  • 52 Week High
  • DXCM $141.99
  • CCEP $88.39
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 33.19
  • CCEP 62.74
  • Support Level
  • DXCM $69.92
  • CCEP $83.21
  • Resistance Level
  • DXCM $76.01
  • CCEP $87.44
  • Average True Range (ATR)
  • DXCM 2.45
  • CCEP 1.56
  • MACD
  • DXCM -0.17
  • CCEP 0.12
  • Stochastic Oscillator
  • DXCM 20.36
  • CCEP 92.56

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About CCEP Coca-Cola Europacific Partners plc

CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe (80% of 2023 revenue and EBIT) and Australasia (20%).In 2023, CCEP sold 3.3 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke's largest bottler, Coca-Cola Femsa sold 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.

Share on Social Networks: